AIMS/HYPOTHESIS: Structural and functional imaging of the islets of Langerhans and the insulin-secreting beta cells represents a significant challenge and a long-lasting objective in diabetes research. In vivo microscopy offers a valuable insight into beta cell function but has severe limitations regarding sample labelling, imaging speed and depth, and was primarily performed on isolated islets lacking native innervations and vascularisation. This article introduces extended-focus optical coherence microscopy (xfOCM) to image murine pancreatic islets in their natural environment in situ, i.e. in vivo and in a label-free condition. METHODS: Ex vivo measurements on excised pancreases were performed and validated by standard immunohistochemistry to investigate the structures that can be observed with xfOCM. The influence of streptozotocin on the signature of the islets was investigated in a second step. Finally, xfOCM was applied to make measurements of the murine pancreas in situ and in vivo. RESULTS: xfOCM circumvents the fundamental physical limit that trades lateral resolution for depth of field, and achieves fast volumetric imaging with high resolution in all three dimensions. It allows label-free visualisation of pancreatic lobules, ducts, blood vessels and individual islets of Langerhans ex vivo and in vivo, and detects streptozotocin-induced islet destruction. CONCLUSIONS/ INTERPRETATION: Our results demonstrate the potential value of xfOCM in high-resolution in vivo studies to assess islet structure and function in animal models of diabetes, aiming towards its use in longitudinal studies of diabetes progression and islet transplants.
AIMS/HYPOTHESIS: Structural and functional imaging of the islets of Langerhans and the insulin-secreting beta cells represents a significant challenge and a long-lasting objective in diabetes research. In vivo microscopy offers a valuable insight into beta cell function but has severe limitations regarding sample labelling, imaging speed and depth, and was primarily performed on isolated islets lacking native innervations and vascularisation. This article introduces extended-focus optical coherence microscopy (xfOCM) to image murinepancreatic islets in their natural environment in situ, i.e. in vivo and in a label-free condition. METHODS: Ex vivo measurements on excised pancreases were performed and validated by standard immunohistochemistry to investigate the structures that can be observed with xfOCM. The influence of streptozotocin on the signature of the islets was investigated in a second step. Finally, xfOCM was applied to make measurements of the murine pancreas in situ and in vivo. RESULTS: xfOCM circumvents the fundamental physical limit that trades lateral resolution for depth of field, and achieves fast volumetric imaging with high resolution in all three dimensions. It allows label-free visualisation of pancreatic lobules, ducts, blood vessels and individual islets of Langerhans ex vivo and in vivo, and detects streptozotocin-induced islet destruction. CONCLUSIONS/ INTERPRETATION: Our results demonstrate the potential value of xfOCM in high-resolution in vivo studies to assess islet structure and function in animal models of diabetes, aiming towards its use in longitudinal studies of diabetes progression and islet transplants.
Authors: Su-Jin Kim; Doris J Doudet; Andrei R Studenov; Cuilan Nian; Thomas J Ruth; Sanjiv Sam Gambhir; Christopher H S McIntosh Journal: Nat Med Date: 2006-12-03 Impact factor: 53.440
Authors: Fabiola Souza; Matthew Freeby; Kristi Hultman; Norman Simpson; Alan Herron; Piotr Witkowsky; Eric Liu; Antonella Maffei; Paul E Harris Journal: Curr Med Chem Date: 2006 Impact factor: 4.530
Authors: Joo Ho Tai; Paula Foster; Alma Rosales; Biao Feng; Craig Hasilo; Violetta Martinez; Soha Ramadan; Jonatan Snir; C W James Melling; Savita Dhanvantari; Brian Rutt; David J G White Journal: Diabetes Date: 2006-11 Impact factor: 9.461
Authors: Hans-Ulrich Dodt; Ulrich Leischner; Anja Schierloh; Nina Jährling; Christoph Peter Mauch; Katrin Deininger; Jan Michael Deussing; Matthias Eder; Walter Zieglgänsberger; Klaus Becker Journal: Nat Methods Date: 2007-03-25 Impact factor: 28.547
Authors: James Sharpe; Ulf Ahlgren; Paul Perry; Bill Hill; Allyson Ross; Jacob Hecksher-Sørensen; Richard Baldock; Duncan Davidson Journal: Science Date: 2002-04-19 Impact factor: 47.728
Authors: Corinne Berclaz; Anja Schmidt-Christensen; Daniel Szlag; Jerome Extermann; Lisbeth Hansen; Arno Bouwens; Martin Villiger; Joan Goulley; Frans Schuit; Anne Grapin-Botton; Theo Lasser; Dan Holmberg Journal: Diabetologia Date: 2015-11-27 Impact factor: 10.122
Authors: Erwin Ilegems; Andrea Dicker; Stephan Speier; Aarti Sharma; Alan Bahow; Patrick Karlsson Edlund; Ingo B Leibiger; Per-Olof Berggren Journal: Proc Natl Acad Sci U S A Date: 2013-11-18 Impact factor: 11.205
Authors: Corinne Berclaz; Daniel Szlag; David Nguyen; Jérôme Extermann; Arno Bouwens; Paul J Marchand; Julia Nilsson; Anja Schmidt-Christensen; Dan Holmberg; Anne Grapin-Botton; Theo Lasser Journal: Biomed Opt Express Date: 2016-10-17 Impact factor: 3.732
Authors: Ken Coppieters; Marianne M Martinic; William B Kiosses; Natalie Amirian; Matthias von Herrath Journal: PLoS One Date: 2010-12-23 Impact factor: 3.240
Authors: Corinne Berclaz; Joan Goulley; Martin Villiger; Christophe Pache; Arno Bouwens; Erica Martin-Williams; Dimitri Van de Ville; Anthony C Davison; Anne Grapin-Botton; Theo Lasser Journal: Biomed Opt Express Date: 2012-05-14 Impact factor: 3.732
Authors: K Andralojc; M Srinivas; M Brom; L Joosten; I J M de Vries; D L Eizirik; O C Boerman; P Meda; M Gotthardt Journal: Diabetologia Date: 2012-02-23 Impact factor: 10.122